Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)

Overview of attention for article published in Journal of Clinical Oncology, January 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog

twitter: 39 X users
facebook: 2 Facebook pages

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

¿Una victoria para la trabectedina en el liposarcoma mixoide de alto grado?

Espanol.news, 03 Feb 2024

La trabectedina neoadyuvante (Yondelis) para el liposarcoma mixoide de alto grado (HG-MLPS) demostró no inferioridad con…

A Win for Trabectedin in High-Grade Myxoid Liposarcoma?

MedPage Today, 02 Feb 2024

Oncology/Hematology > Other Cancers Statistics support noninferiority versus more toxic chemotherapy, but results far from…

Neoadjuvant Trabectedin Noninferior to Standard Care for High-Grade Myxoid Liposarcoma

Cancer Therapy Advisor, 31 Jan 2024

Neoadjuvant trabectedin may be an alternative to standard chemotherapy for patients with high-grade myxoid liposarcoma of the…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.